RapidAI

iSchemaView

Published by: iSchemaView
Downloads
Revenue

Description

RapidAI is the global leader in using AI to combat life-threatening vascular and neurovascular conditions. Leading the next evolution of clinical decision-making and patient workflow, RapidAI is empowering physicians to make faster decisions for better patient outcomes. Based on intelligence gained from nearly 10 million scans in more than 2,000 hospitals in over 100 countries, the Rapid® platform transforms care coordination, offering care teams a level of patient visibility never before possible. RapidAI – where AI meets patient care.
Physicians can now save precious time with anywhere, anytime notifications of new patient cases and access to RapidAI results and compressed patient images on their mobile device.
Rapid Mobile App Features:
- Real-time notifications of new case events and messages
- Access to RapidAI results and patient images in as few as 90 seconds of a patient scan
- Compressed source file viewing through DICOM viewer
- Full screen zoom functionality and landscape mode
- Image rotation for axial, coronal and sagittal views
- View and organize case results from multiple sites
- Flexible configuration options for PHI, biometrics, Single Sign On and multi-factor authentication
- Centralized views of patient events, messages, and results
- Fast notification and coordination of stroke teams for critical cases
- Simple entry of key clinical information and ability to upload photos to the message feed
- In-app calling for quicker communications with stroke team members
The Rapid Mobile App is not for diagnostic decision making. Refer to the PACS or clinical system for case evaluation.
Hide Show More...

Screenshots

RapidAI FAQ

  • Is RapidAI free?

    Yes, RapidAI is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is RapidAI legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does RapidAI cost?

    RapidAI is free.

  • What is RapidAI revenue?

    To get estimated revenue of RapidAI app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in Norway yet.
Ratings History

RapidAI Reviews

Slow login/ multiple attempts

Arash Sha on

United States

The login process takes time and fails 1-2 times before successfully gettin ing. Time consuming!

NeuroNerd

NeuroNerdNY on

United States

The glitches are very frustrating. When trying to look at imaging quickly, it is hit or miss to log in through the app. Needs work.

Randomly stops sending info

Soli yoga on

United States

Keeps logging me out. More often than not when I log in it erroneously tells me I have no sites set up. I rarely get the notifications that I’m signed up for. Great idea, terrible execution.

Great advance for the modern treatment of stroke!

Asinghal on

United States

Works great excited to see this advancement in providing artificial intelligence at your fingertips for stroke care

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
Chart
Category
Rank
Top Free
300

RapidAI Competitors

Name
CorePendium
The Crucial Clinical Reference
EM:RAP - Medical Education
Emergency Medicine & Beyond
AAN Continuum Audio
Neurology Question of the Day
Self-assessment CME
Viz.ai
Neurosurgical Atlas
Neurosurgical Atlas
SIR Guidelines
Neuro Toolkit
AAN Conferences
Teladoc Health Provider Access

RapidAI Installs

Last 30 days

RapidAI Revenue

Last 30 days

RapidAI Revenue and Downloads

Gain valuable insights into RapidAI performance with our analytics.
Sign up now to access downloads, revenue, and more.

App Info

This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.